Low Evidence
Research Overview
LL-37 Research for Inflammation
An evidence-based overview of research examining LL-37 in the context of inflammation. This page synthesizes findings from peer-reviewed literature.
Research Summary
LL-37 responses depend on tissue and processing. Human rosacea tissue and laboratory immune-cell studies associate cathelicidin signaling with inflammation, while a 2026 bronchial-cell study found different responses for LL-37 and its citrullinated form. These mechanisms are not proof of a clinical anti-inflammatory treatment.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.